Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Burst CME™: Disease-Modifying vs. Curative Therapy – Which Way to Go in Sickle Cell Disease?
Matthew Heeney, MD; Biree Andemariam, MD
Optimizing Lipid-Lowering Strategies for ASCVD Risk Reduction: Bridging the Gap in Treatment Intensification
Erin D. Michos, MD, MHS; Nihar Desai, MD, MPH
Cases & Conversations™: Unmasking Epithelioid Sarcoma – Enhancing Early Diagnosis and Multidisciplinary Care
Mark Agulnik, MD; Mrinal M. Gounder, MD; Sandra D’Angelo, MD; Sujana Movva, MD
Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis
Abigail Schwaede, MD; Alexis Lizarraga, MD, MS
Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data
John V. Heymach, MD, PhD; Anne S. Tsao, MD, MBA, FASCO, FACHE
Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis
Michelle Petri, MD, MPH; Shivani Garg, MD, PhD
SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer
Rachel N. Grisham, MD
Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies
Onyema Ogbuagu, MD, FACP, FIDSA
Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis
James F. Howard Jr, MD, FAAN; Tuan Vu, MD
The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes
Uday Devgan, MD, FACS, FRCS
Advances In™: A Glimpse Into the Future Care of Platinum-Resistant Ovarian Cancer
Alexander Olawaiye, MD; Alison Schram, MD
Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)
James F. Howard Jr, MD, FAAN; Tuan Vu, MD
Cases and Conversations™: Navigating CKD and Heart Failure in T1D and T2D—Applying the Latest Guidelines and Evidence
Stephen J Greene, MD; Anuradha Lala-Trindade, MD
The Rise of Novel HER2-Targeting Therapies in GEA: Mechanisms and Clinical Data
Rahul Gosain, MD, MBA; Rohit Gosain, MD
Animated Burst CME™: From Gene to Gut: Understanding TL1A’s Function in IBD Evolution
Jordan E. Axelrad, MD, MPH, FACG
Community Practice Connections™: Beyond Primary End Points: Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer
Seth A. Wander, MD, PhD; Marla D. Lipsyc-Sharf, MD
Oncology Town Hall: Shaping the Future of ALL Treatment Through Innovation in T-Cell Therapies
Claire Roddie, MD, PhD; Elias Jabbour, MD; Hagop Kantarjian, MD
Tackling Oncologic Emergencies in Patients Treated With High-Dose Methotrexate
Shazia Nakhoda, MD; Shruti Gupta, MD, MPH; Anitha Varghese, MSN, APRN, AGPCNP-C
Revolutionizing TGCT Care with Multidisciplinary Perspectives and Cutting-Edge Targeted Therapies
Mark Agulnik, MD; Lee M. Zuckerman, MD
From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC
Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD
Advances in™: Lipoprotein(a) as a Target for ASCVD Risk Reduction – Updates for Clinical Practice
Pam R. Taub, MD, FACC, FASPC; Payal Kohli, MD, FACC
Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease
Michelle Petri, MD, MPH; Shivani Garg, MD, PhD
Collaborating Across the Continuum®: Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
John Koo, MD; T.J. Chao, MPAS, PA-C
Visualizing the Role of the Complement Pathway in Paroxysmal Nocturnal Hemoglobinuria
Caroline Piatek, MD; Jamile M. Shammo, MD, FASCP, FACP
Community Practice Connections™ Next Generation Therapies in AML: Menin Inhibitors, IDH1/2, Combinations, and Beyond!
Naval Daver, MD
Medical Crossfire™: Navigating the Expanding Arsenal of Endocrine Therapies for HR+/HER2- Metastatic Breast Cancer – How Can PROTAC ER Degradation Shift the Standard?
William J. Gradishar, MD, FASCO, FACP; Stephanie L. Graff, MD, FACP, FASCO; Cynthia X. Ma, MD, PhD
Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP inhibition in Triple-Negative Breast Cancer
Hope S. Rugo, MD; Alison K. Conlin, MD; Marleen Kok, MD, PhD; Heather McArthur, MD, MPH
Medical Crossfire®: From Frontline to Heavily Pretreated HR+/HER2- Metastatic Breast Cancer: Expert Perspectives on Optimizing the Expanding Treatment Armamentarium
Erika P. Hamilton, MD; Giuseppe Curigliano, MD, PhD; VK Gadi, MD, PhD; Jason Aboudi Mouabbi, MD
Show Me the Data™: Personalizing First-Line and Maintenance Therapy in HER2+ Metastatic Breast Cancer to Extend Survival and Elevate Quality of Life
Sara A. Hurvitz, MD, FACP; Rena Callahan, MD; Michelle Melisko, MD; Paolo Tarantino, MD, PhD
Medical Crossfire®: Mastering the Nuances of Early-Stage HR+/HER2- Breast Cancer—Expert Perspectives on Applying Modern Treatment Paradigms
Tiffany A. Traina, MD, FASCO; Kevin Kalinsky, MD MS, FASCO; Mark E. Robson, MD, FASCO; Rebecca Shats...
ISGIO 2025: Pancreatic and Neuroendocrine Tumors
Laura Dawson, MD, FRCPC, FASTRO; Thorvardur R. Halfdanarson, MD; Eileen M. O’Reilly, MD, FASCO; Scot...
ISGIO 2025: Hepatobiliary Cancers
Natasha Bahri, MD, MSc; Ashton A. Connor, MD, PhD; James J. Harding, MD; Daneng Li, MD; Shubham Pant...
ISGIO 2025: Esophageal and Gastric Cancer
Joanna Mycek, MD; M. Bassam Sonbol, MD; Matthew R. Strickland, MD; Vivian E. Strong, MD, FACS
ISGIO 2025: Early-Stage Colorectal Cancer
Kristen K. Ciombor, MD, MSCI; Stacey A. Cohen, MD; Eric D. Miller, MD, PhD; Van Karlyle Morris, MD; ...
ISGIO 2025: Advanced-Stage Colorectal Cancer
Cody Eslinger, MD, MS; Christopher Lieu, MD; Eric D. Miller, MD, PhD; Michael J. Overman, MD; Christ...
Screening for Type 1 Diabetes and Delaying Its Onset—An Innovative View
Jennifer D. Goldman, PharmD, RPh, CDCES, BC-ADM, FCCP; Robert Busch, MD; Conan Tu, MD, MBA, DACD, BC...
Hot Seat: Converging Lines in the Management of RAS-Altered Cancers
Shubham Pant, MD, MBBS; Alison Schram, MD; Helena Yu, MD
Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida
Carl J. Danzig, MD, FASRS
Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California
Dilsher S. Dhoot, MD, FASRS
Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD
Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis
Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO